2024 Summit Schedule

Enjoy browsing through all that the 2024 Summit has to offer!

ACPE = Approved for ACPE Credit.
BCPP = Additional registration is required to earn BCPP Recertification credit.
= Registered attendees will see a clipboard icon to quickly access exams or evaluations for ACPE credit.

Thursday, October 10, 2024
9:00 AM - 10:15 AM

Chronic Pain and Depression/Anxiety: Addressing the Cycle ACPE
Audrey A. Abelleira, PharmD, BCPS, BCPP
ACPE #: 0284-0000-24-058-H08-P (Application) (1.25 hours)
10:30 AM - 11:45 AM

Managing Pain and Co-Occurring Opioid Disorder: Dispelling Myths to Improve Care ACPE
Michelle Krichbaum, PharmD, BCPP
ACPE #: 0284-0000-24-059-H08-P (Application) (1.25 hours)
12:00 PM - 1:15 PM

Impact of Social Determinants of Health on Psychotropic Long-Acting Injectable Access and Administration | Grant Supported by Otsuka America Pharmaceutical, Inc. and Lundbeck ACPE
Robert G. Sise, MD, MBA, MPH
ACPE #: 0284-0000-24-066-H04-P (Knowledge) (1.0 hours)
1:30 PM - 2:45 PM

Use of Psychedelics for the Treatment of Substance Use Disorders ACPE
Christopher Nicholas, PhD
ACPE #: 0284-0000-24-060-H01-P (Application) (1.25 hours)
3:00 PM - 4:15 PM

Impact of Microaggressions on Practice ACPE
John M. Allen, PharmD, BCPS, BCCCP, FCCM, FCCP
ACPE #: 0284-0000-24-061-H04-P (Application) (1.25 hours)

Friday, October 11, 2024
9:00 AM - 10:15 AM

You and Me Versus ChatGPT: Assessing the Role of Artificial Intelligence in Health Care ACPE
Charlotte Rosalind Blease, BSc, MA, PhD
ACPE #: 0284-0000-24-064-H99-P (Application) (1.25 hours)
10:30 AM - 11:45 AM

Street Medicine: Psychiatric Care for Individuals who are Unsheltered ACPE
Liz Frye, MD, MPH
ACPE #: 0284-0000-24-063-H01-P (Application) (1.25 hours)
12:00 PM - 1:15 PM

Treatment of Postpartum Depression: Focus on the Role and Clinical Considerations for Neuroactive Steroids | Grant Supported by Sage Therapeutics, Inc. and Biogen, Inc. ACPE
Lauren M. Osborne, MD
ACPE #: 0284-0000-24-067-H01-P (Knowledge) (1.0 hours)
1:30 PM - 2:45 PM

Management of Attention-Deficit/Hyperactivity Disorder (ADHD): Considerations for Adults ACPE
Daina L. Wells, PharmD, MBA, BCPP
ACPE #: 0284-0000-24-062-H01-P (Application) (1.25 hours)
3:00 PM - 4:15 PM

Benzodiazepine-Induced Neurological Dysfunction ACPE
Jeff D. Gold, PharmD, BCPP; Alexis Ritvo, MD, MPH
ACPE #: 0284-0000-24-065-H01-P (Application) (1.25 hours)

2024 Summit

2024 Summit Schedule

Thursday, October 10, 2024

Friday, October 11, 2024